Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,993,980
+$20,460,288 QoQ
Shares Held
201,159
+34.7% QoQ
Ownership
0.469%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#48
of 870 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Mar 31, 2026CallValue
$6,404,184
CallShares
10,800
PutValue
$6,285,588
PutShares
10,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
201,159 | $108,993,980 | |
| 2 | HLN |
Haleon plc
|
9,264,255 | $86,435,499 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
629,806 | $69,870,677 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,250,639 | $51,313,718 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
659,493 | $42,174,577 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,059,778 | $35,905,278 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
2,235,821 | $11,022,597 | |
| 8 | EOLS |
Evolus, Inc.
|
1,508,518 | $10,469,114 |
All Filings in UTHR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,993,980 | 201,159 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,404,184 | 10,800 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $6,285,588 | 10,600 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $88,533,692 | 149,303 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $90,708,409 | 186,164 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $41,830,450 | 99,784 | Shares | Defined | 2025-11-14 | |
| 2024-03-31 | $37,375,444 | 162,700 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $234,227 | 1,037 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,626,925 | 11,900 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $4,669,206 | 19,815 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $35,361,711 | 197,100 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $44,771,776 | 207,200 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $38,189,602 | 206,900 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $99,106,084 | 552,400 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $52,094,479 | 343,201 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $44,493,227 | 440,527 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $32,586,389 | 269,309 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $54,920,604 | 579,148 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||